Stephanie L. Graff, MD

Stephanie L. Graff, MD, FACP, FASCO, is the director of the Breast Oncology Program at Brown University Health Cancer Institute, and co-leader of the Breast Cancer Translational Research Disease Group.

Articles by Stephanie L. Graff, MD

The Role of Invasive Disease-Free Survival in Breast Cancer Research

ByStephanie L. Graff, MD

September 6th 2025

Experts explore the potential of invasive disease-free survival as a key metric in breast cancer trials, aiming to accelerate treatment approvals.

Graff on Using the Signatera Assay to Assess ctDNA in Early Breast Cancer

ByStephanie L. Graff, MD

December 8th 2023

Stephanie L. Graff, MD, discusses what a community oncologist should know about her presentation on the Signatera assay in patients with hormone receptor-positive, HER2-negative, node-positive, high-risk early breast cancer after adjuvant abemaciclib and endocrine therapy.

Stephanie L. Graff, MD

Articles by Stephanie L. Graff, MD

The Role of Invasive Disease-Free Survival in Breast Cancer Research

Graff on Using the Signatera Assay to Assess ctDNA in Early Breast Cancer

Latest Updated Articles

Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways

FDA Grants Traditional Approval to Pirtobrutinib in CLL/SLL

Durable Responses With Novel Cell Therapy TARA-002 in BCG-Naive NMIBC

Safusidenib Shows Robust, Ongoing Responses in Grade 2 IDH1-Mutant Glioma

Sac-TMT Demonstrates Antitumor Activity, Safety in Urothelial Carcinoma

JANX007 Shows Promising Efficacy, Safety in Phase 1 Trial Update